These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Immunologic impairment in bronchogenic carcinoma: a study of lymphocyte response to phytohemagglutinin. Han T; Takita H Cancer; 1972 Sep; 30(3):616-20. PubMed ID: 4342406 [No Abstract] [Full Text] [Related]
5. [Effect of different plasmas on the behavior of blastization of lymphocytes from patients with pulmonary neoplasms (preliminary note)]. Pozzi E; Serra R; Menghini P Riv Emoter Immunoematol; 1971; 18(1):43-50. PubMed ID: 5164574 [No Abstract] [Full Text] [Related]
6. Diminished lymphocyte responses to phytohemagglutinin in lung cancer. Hadjipetrou-Kourounakis L; Tsougranis A Biochem Exp Biol; 1980; 16(4):357-64. PubMed ID: 6285942 [TBL] [Abstract][Full Text] [Related]
7. Perspectives in immunotherapy of lung cancer. Hersh EM; Gutterman JU; Mavligit GM Cancer Treat Rev; 1974 Mar; 1(1):65-80. PubMed ID: 4471091 [No Abstract] [Full Text] [Related]
8. Demonstration of immune reactions against cultured hamartoma cells with lymphocytes from patients with bronchogenic carcinoma. Pierce GE; Allingham R; Bell JW Surg Forum; 1972; 23(0):89-91. PubMed ID: 4671035 [No Abstract] [Full Text] [Related]
9. Effect of radiotherapy on lymphocyte cytotoxicity against allogeneic lung cancer cells in patients with bronchogenic carcinoma. Toyohira K; Yasumoto K; Manabe H; Ohta M; Terashima H; Takayama K; Shinohara S; Nomoto K Gan; 1979 Feb; 70(1):9-14. PubMed ID: 446978 [TBL] [Abstract][Full Text] [Related]
10. Immunoprofile studies for patients with bronchogenic carcinoma--I: correlation of pre-therapy studies with stage of diseases. Concannon JP; Dalbow MH; Eng CP; Conway J Int J Radiat Oncol Biol Phys; 1977; 2(5-6):447-54. PubMed ID: 301875 [No Abstract] [Full Text] [Related]
11. Cytotoxic activity of lymphocytes to bronchogenic carcinoma cells in patients with lung cancer. Yasumoto K; Ohta M; Nomoto K Gan; 1976 Aug; 67(4):505-11. PubMed ID: 1030675 [TBL] [Abstract][Full Text] [Related]
12. Cellular immunity in neoplasia. Antigen and mitogen responses in patients with bronchiogenic carcinoma. Rees JC; Rossio JL; Wilson HE; Minton JP; Dodd MC Cancer; 1975 Dec; 36(6):2010-5. PubMed ID: 173458 [TBL] [Abstract][Full Text] [Related]
13. In vivo and in vitro assays of immunocompetence in bronchogenic carcinoma. Alsabti EA Oncology; 1979; 36(4):171-5. PubMed ID: 157453 [TBL] [Abstract][Full Text] [Related]
14. Immunocompetence of patients with bronchogenic carcinoma. Olkowski ZL; McLaren JR; Mansour KA Ann Thorac Surg; 1976 Jun; 21(6):546-51. PubMed ID: 179484 [TBL] [Abstract][Full Text] [Related]
15. Lymphocyte mitogen stimulation studies for patients with lung cancer: evaluation of prognostic significance of preirradiation therapy studies. Dalbow MH; Concannon JP; Eng CP; Weil CS; Conway J; Narayanan Nambisan PT J Lab Clin Med; 1977 Aug; 90(2):295-302. PubMed ID: 886214 [TBL] [Abstract][Full Text] [Related]
16. Assessment of immune responses to tumors using cryostat sections of bronchogenic carcinoma. Erickson AD Cancer Res; 1980 Oct; 40(10):3598-3601. PubMed ID: 7002290 [TBL] [Abstract][Full Text] [Related]
17. Immunologic assays in lung cancer. Skin tests, lymphocyte blastogenesis, and rosette-forming cell count. Brugarolas A; Han T; Takita H; Minowada J N Y State J Med; 1973 Mar; 73(6):747-50. PubMed ID: 4510958 [No Abstract] [Full Text] [Related]
19. [The phenomenon of blastic transformation of lymphocytes in the immunology of neoplastic diseases]. Zhukhina GE Vopr Onkol; 1972; 18(6):91-6. PubMed ID: 4559304 [No Abstract] [Full Text] [Related]
20. [Immunologic status of patients with bronchogenic carcinoma of the lung]. Rowińska-Zakrzewska E; Byszewska D; Grubek-Jaworska H; Zabuska-Jabłońska K; Plucińska M Pneumonol Pol; 1979 Apr; 47(4):221-30. PubMed ID: 313046 [No Abstract] [Full Text] [Related] [Next] [New Search]